VIKING THERAPEUTICS INC

Ticker: VKTX CUSIP: 92686J106 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 207,873 Value ($000) $5,020 Avg Close $31.61 Range $23.27 - $43.55
Q4 2024
Shares 20,114 Value ($000) $809 Avg Close $57.02 Range $37.80 - $81.73
Q3 2024
Shares 17,858 Value ($000) $1,131 Avg Close $58.67 Range $47.31 - $72.36
Q2 2024
Shares 73,700 Value ($000) $3,907 Avg Close $65.55 Range $46.11 - $82.00
Q1 2024
Shares 371,686 Value ($000) $30,478 Avg Close $44.50 Range $17.23 - $99.41
Q4 2023
Shares 102,855 Value ($000) $1,914 Avg Close $13.08 Range $8.28 - $20.03
Q3 2023
Shares 52,558 Value ($000) $582 Avg Close $14.30 Range $10.66 - $16.36
Q2 2023
Shares 133,190 Value ($000) $2,159 Avg Close $20.95 Range $14.30 - $25.72
Q1 2023
Shares 84,723 Value ($000) $1,411 Avg Close $10.33 Range $7.97 - $17.60
Q4 2022
Shares 70,335 Value ($000) $661 Avg Close $4.46 Range $2.68 - $9.62
Q3 2022
Shares 1,337,380 Value ($000) $3,638 Avg Close $3.28 Range $2.54 - $3.90